Category: Hematology & Oncology
Global Hematology & Oncology
-
Global Oncology Molecular Diagnostics Market 2024
... based on patient-specific molecular profiles. Partnerships drive innovation in molecular tests, while immuno-oncology treatments and advanced technologies improve patient outcomes. Rising cancer prevalence underscores the need for accurate diagnostics, leading to a transformation in precision ... Read More
-
Global Prostate Cancer Antigen 3 Test Market Insights, Forecast to 2030
... at a CAGR of 9.09% during 2024-2030. The US & Canada market for Prostate Cancer Antigen 3 Test is estimated to increase from $ 19.1 million in 2023 to reach $ 34.31 million by 2030, ... Read More
-
2024 Global Cancer Diagnostics Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Forecast for In-vitro diagnostic substances, hematology products (2025-2030 Outlook)-Manufacturing & Markets Report
... accurate market statistics and forecasts on the market for over 40 countries. The product category is within the NAICS 32511 industry. Estimates on equipment or material sales (product shipments value) are published historically for 2017 ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
2024 Global: Cancer Diagnostics Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
Monoclonal Antibody (mABs) Therapeutics Market by Production Method (In-Vitro, In-Vivo), Sources (Human, Chimeric), Route of Administration (Intravenous, Subcutaneous), Therapy (Inflammatory & Autoimmune, Oncology, Hematology) - Global Forecast to 2029
... projected to reach USD 497.5 billion by 2029 from an estimated USD 252.6 billion in 2024, at a CAGR of 14.5% during the forecast period. The driving factors of the monoclonal antibody therapeutics market include ... Read More
-
2024 World Hematology and Flow Cytometry Database: 98 Countries - Analyzers and Reagents, Supplier Shares, Test Volume and Sales Segment Forecasts
... forecasts for major hematology and flow cytometry tests, including: Hematology Tests CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, ... Read More
-
2023 Global Hematology Market Shares in the US, Europe, and Japan - Competitive Analysis of Leading and Emerging Market Players
... US. The report analyses current and emerging suppliers of hematology analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. The companies profiled in ... Read More
-
Flow Cytometry Market Assessment, By Products and Service [Instruments, Kits and Reagents, Software and Services, Others], By Technology [Cell-based Flow Cytometry, Bead-based Flow Cytometry], By Application [Oncology, Drug Discovery, Stem Cell Therapy, Hematology, Immunology, Other Applications], By End-user [Hospitals, Clinical Testing Laboratories, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F
... Applications], By End-user [Hospitals, Clinical Testing Laboratories, Academic and Research Institutes, Others], By Region, Opportunities and Forecast, 2017-2031F Global flow cytometry market is projected to witness a CAGR of 7.89% during the forecast period 2024-2031, ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Brain Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Diagnostic Type (Imaging Test, Lumbar Puncture, Biopsy, Molecular Testing, Platform and Services, Cerebral Arteriogram, Neurological & Hearing Tests/Neurocognitive Assessments, Electroencephalography, EEG, Others), By Cancer (Acoustic Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, Others), By Tumor Size (0.2 cm3 to 100 cm3, 101 cm3 to 200 cm3, Above 200 cm3), by Region, Country, Segment, and Companies, 2024-2030
... Neuroma, Astrocytomas, Craniopharyngiomas, Ganglioneuromas, Glioblastoma Multiforme, Meningiomas, Ependymomas, Oligodendroglioma, Low-Grade Tumors, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Diagnostic Centers & Research Institutes, Others), By Tumor Size (0.2 cm3 to 100 cm3, 101 ... Read More
-
Research Antibodies Market Size, Trends, Analysis, and Outlook By Product(Primary Antibodies, Secondary Antibodies), By Type(Monoclonal Antibodies,Polyclonal Antibodies), By Technology(Immunohistochemistry, Immunofluorescence, Western Blotting, Flow Cytometry, Immunoprecipitation, ELISA, Others), By Source(Mouse, Rabbit, Goat, Others), By Application(Infectious Diseases, Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030
... Immunology, Oncology, Stem Cells, Neurobiology, Others), By End-user(Academic & Research Institutes, Contract Research Organizations, Pharmaceutical & Biotechnology Companies), by Region, Country, Segment, and Companies, 2024-2030 The global Research Antibodies market size is poised to register ... Read More
-
Next Generation Cancer Diagnostics Market Size, Trends, Analysis, and Outlook By Technology (Next-generation Sequencing, qPCR & Multiplexing, Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays), By Application (Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, 2024-2030
... Proteomic Analysis, Epigenetic Analysis, Genetic Analysis), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Cervical Cancer, Others), By Function, Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis), by Region, Country, Segment, and Companies, ... Read More
-
Single-cell Omics Market Size, Trends, Analysis, and Outlook By Product (Single-Cell Genomics, Single-Cell Transcriptomics, Single-Cell Proteomics, Single-Cell Metabolomics), By Application (Oncology, Cell Biology, Neurology, Immunology), By End-user (Academic and Research Organizations, Pharmaceutical & Biotechnology Companies, Hospital and Diagnostic Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... Hospital and Diagnostic Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Single-cell Omics market size is poised to register 18.3% growth from 2024 to 2030, presenting significant growth prospects for companies operating ... Read More
-
Point of Care Diagnostics Market by Product (Glucose, HIV, Hep C, HPV, Hematology, Pregnancy), Platform (Microfluidic, Dipstick, RT-PCR, INAAT), Sample(Blood, Urine), Purchase (OTC, Rx), End User (Pharmacy, Hospitals, Home Care) - Global Forecast to 2028
... The point of care diagnostics market is epected to reach USD 77.8 billion by 2028 from an estimated USD 49.7 billion at a CAGR of 9.4% during the forecast period (2023–2028).The gobal rising burden of ... Read More
-
Point of Care Diagnostics Market Size, Trends, Analysis, and Outlook By Product(Glucose Testing, Hb1Ac Testing, Coagulation Testing, Fertility/Pregnancy, Infectious Disease , Cardiac Markers, Thyroid, Stimulating Hormone, Hematology, Primary Care Systems, Decentralized Clinical Chemistry, Feces, Lipid Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030
... Testing, Cancer Marker, Blood Gas/Electrolytes, Ambulatory Chemistry, Drug of Abuser (DOA) Testing, Autoimmune Diseases, Urinalysis/Nephrology), By End user(Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory), by Region, Country, Segment, and Companies, 2024-2030 The global Point ... Read More
-
The 2025-2030 World Outlook for Immune-Oncology Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Immuno Oncology Assays
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Oncology Molecular Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Liver Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Therapies and Diagnostics for Ovarian Cancers
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Precision Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Tissue Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Cervical Cancer Diagnostics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
Research Assistance
